The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20071143
The Journal of Experimental Medicine, Vol. 204, No. 10, 2285-2291
The Rockefeller University Press, 0022-1007 $30.00
© Andzelm et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2021K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andzelm, M. M.
Right arrow Articles by Strominger, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andzelm, M. M.
Right arrow Articles by Strominger, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

Myosin IIA is required for cytolytic granule exocytosis in human NK cells

Milena M. Andzelm1, Xi Chen1, Konrad Krzewski1, Jordan S. Orange1,2, and Jack L. Strominger1

1 Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138
2 Children's Hospital of Philadelphia, Division of Immunology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

CORRESPONDENCE Jack L. Strominger: jlstrom{at}fas.harvard.edu OR Jordan S. Orange: orange{at}mail.med.upenn.edu

Natural killer (NK) cell cytotoxicity involves the formation of an activating immunological synapse (IS) between the effector and target cell through which granzymes and perforin contained in lytic granules are delivered to the target cell via exocytosis. Inhibition of nonmuscle myosin II in human NK cells with blebbistatin or ML-9 impaired neither effector–target cell conjugation nor formation of a mature activating NK cell IS (NKIS; formation of an actin ring and polarization of the microtubule-organizing center and cytolytic granules to the center of the ring). However, membrane fusion of lytic granules, granzyme secretion, and NK cell cytotoxicity were all effectively blocked. Specific knockdown of the myosin IIA heavy chain by RNA interference impaired cytotoxicity, membrane fusion of lytic granules, and granzyme secretion. Thus, myosin IIA is required for a critical step between NKIS formation and granule exocytosis.


Abbreviations used: BDM, 2,3-butane-dione monoxime; cSMAC, central SMAC; IS, immunological synapse; NKIS, NK cell IS; pNK, peripheral blood NK; pSMAC, peripheral SMAC; RNAi, RNA interference; SMAC, supramolecular activation cluster; WASp, Wiskott-Aldrich syndrome protein.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS